Canadian Cancer Society (2020). ON-specific stats 2020, Retrieved from: https://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics%20supplementary%20information/2020/ON-specific-stats-2020.pdf?la=en
Goldkuhle, M., Ernst, M., Estcourt, L. J., Borchmann, P., Monsef, I., & Skoetz, N. (2019). Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma. The Cochrane Database of Systematic Reviews, 2019(6), CD013365. https://doi.org/10.1002/14651858.CD013365
Lee, D. W., Santomasso, B. D., Locke, F. L., Ghobadi, A., Turtle, C. J., Brudno, J. N., . . . Neelapu, S. S. (2019). ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells. Biology of Blood and Bone Marrow Transplantation, 25(4), 625-638.
Lymphoma Canada (2020). Diffuse Large B-Cell Lymphoma (DLBCL), Retrieved from: https://www.lymphoma.ca/diffuse-large-b-cell-lymphoma/
Morrison, V. A., Hamlin, P., Soubeyran, P., Stauder, R., Wadhwa, P., Aapro, M., & Lichtman, S. (2015). Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper. Journal of geriatric oncology, 6(2), 141–152. https://doi.org/10.1016/j.jgo.2014.11.004
Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W., Gutierrez, C., Locke, F. L., Komanduri, K. V., Lin, Y., Jain, N., Daver, N., Westin, J., Gulbis, A. M., Loghin, M. E., de Groot, J. F., Adkins, S., Davis, S. E., Rezvani, K., Hwu, P., & Shpall, E. J. (2018). Chimeric antigen receptor T-cell therapy – assessment and management of toxicities. Nature reviews. Clinical oncology, 15(1), 47–62. https://doi.org/10.1038/nrclinonc.2017.148
Novartis Pharmaceuticals Canada Inc. (2018). Kymriah (Tisangenlecleucel) Suspension for IV infusion – Product Monograph, Retrieved from: https://pdf.hres.ca/dpd_pm/00047188.PDF
Schuster, S. J., Bishop, M. R., Tam, C. S., Waller, E. K., Borchmann, P., McGuirk, J. P., Jäger, U., Jaglowski, S., Andreadis, C., Westin, J. R., Fleury, I., Bachanova, V., Foley, S. R., Ho, … JULIET Investigators (2019). Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The New England journal of medicine, 380(1), 45–56. https://doi.org/10.1056/NEJMoa1804980